“Long-Term Durability and Stability of Amlitelimab Efficacy in Adults With Moderate-to-Severe Atopic Dermatitis: 52-Week Post Hoc Analysis of the STREAM-AD Phase 2b Trial”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s607. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/3813.